Balchem BCPC Gain (Loss) on Sale of Assets and Asset Impairment Charges
Gain (Loss) on Sale of Assets and Asset Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Balchem in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges.
The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Balchem's gain (loss) on sale of assets and asset impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Balchem's gain (loss) on sale of assets and asset impairment charges?
- Balchem (BCPC) reported gain (loss) on sale of assets and asset impairment charges of -$151K in Q1 2026.
- How has Balchem's gain (loss) on sale of assets and asset impairment charges changed year-over-year?
- Balchem's gain (loss) on sale of assets and asset impairment charges decreased by 132.3% year-over-year, from -$65K to -$151K.
- What does gain (loss) on sale of assets and asset impairment charges mean?
- This metric captures the net impact of gains or losses realized from the disposal of property, plant, equipment, or other long-term assets, alongside any charges related to asset impairment. It serves as a reconciliation adjustment to remove non-recurring, non-operating items from net income to better reflect the cash-generating capability of ongoing business activities. Investors use this to assess the quality of earnings by identifying one-time events that distort operational performance.